Live Breaking News & Updates on Impel Pharmaceuticals Inc|Page 5

Stay updated with breaking news from Impel pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Billionaire Marc Lasry's Top 10 Stock Picks

In this piece, we will take a look at billionaire Marc Lasry’s top ten stock picks. If you want to skip our introduction to the billionaire hedge fund boss and the general investing climate, then take a look at Billionaire Marc Lasry’s Top 5 Stock Picks. Marc Lasry is a hedge fund billionaire who started […] ....

United States , Aaron Weitman Castleknight , Marc Lasry , Albert Cha , Frank Kung Vivo , Energy Corp , Seadrill Limited , Number Of Hedge Fund Investors , Orchestra Biomed Holdings Inc , Impel Pharmaceuticals Inc , Exchange Commission , Exela Technologies Inc , Forge Global Holdings Inc , Eyenovia Inc , Sitio Royalties Corp , Avenue Capital , Hedge Fund Investors , Insider Monkey , Exela Technologies , Aaron Weitman , Castleknight Management , Amplify Energy , Sitio Royalties , Biomed Holdings , New Hope , Joseph Edelman ,

Impel NeuroPharma Inc. (IMPL) Announces Exploration of Strategic Alternatives

Impel NeuroPharma Inc. (IMPL) Announces Exploration of Strategic Alternatives
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Moelis Company , Impel Pharmaceuticals Inc , Impel Pharmaceuticals , Trudhesa Direct ,

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) Impel Pharmaceuticals Inc. (NASDAQ: IMPL) (“Impel” or “the Company”), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering ....

Michael Kalb , Moelis Company , Impel Pharmaceuticals Inc , Trudhesa Direct , Forward Looking , Securities Litigation Reform Act ,

Short Interest in Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Declines By 12.7%

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 505,100 shares, a drop of 12.7% from the August 15th total of 578,800 shares. Currently, 6.5% of the company’s stock are short sold. Based on an average daily volume […] ....

United States , Impel Pharmaceuticals , Tower Research Capital , Impel Pharmaceuticals Inc , Institutional Investors Weigh In On Impel Pharmaceuticals , News Ratings For Impel Pharmaceuticals Daily , Raymond James Associates , Goldman Sachs Group Inc , Impel Pharmaceuticals Company Profile , Impel Pharmaceuticals Trading Down , Citadel Advisors , Get Free Report , Pharmaceuticals Trading Down , Research Capital , Sachs Group , Street Group , Raymond James , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl ,